The N 1 -alkylation of 4-(trichloromethyl)pyrimidin-2(1H)-one, 4-methoxy-4-(trichloromethyl)-3,4-dihydropyrimidin-2(1H)-one, and 5-bromo-4-methoxy-4-(trichloromethyl)-3,4-dihydropyrimidin-2(1H)-one with selected alkylating agents such as 2-chloroacetamide, diethyl 2-bromomalonate, and 5-bromo-1,1,1-trichloro-4-methoxypent-3-en-2-one, is presented. Further reactions of 1-[5,5,5-trichloro-2-methoxy-4-oxo-penten-2-yl]4-trichloromethyl-pyrimidin-2(1H)-one with primary amines and aminoalcohols furnished a series of unexpected new acyclic nucleoside analogues.
Introduction
Pyrimidines have a long history of biological activity and utilization in fields ranging from pharmaceutics to agriculture. [1] [2] [3] The N 1 -alkylation of pyrimidines is one way of functionalizing the pyrimidine ring to achieve important physical and bioactive properties. For example, N-alkylated nucleic acid bases are widely known for being the most effective antiviral [4] [5] [6] [7] and antitumoral agents, 8 as well as for exhibiting antiinflammatory 9 and herbicidal activity. 10, 11 In addition, N-alkylated pyrimidines, obtained by alkylating agents such as diazoalkanes 12 alkylhalides [13] [14] [15] and alkylsulfates, among others, 16 are important compounds for mutagenic and carcinogenic studies in living systems. Additionally, a series of N 1 -(4-substituted-benzyl)-pyrimidines was identified as potent and selective inhibitors of the thymidine monophosphate kinase of Micobacterium tuberculosis (TMPKmt), making them a promising target for the development of new antitubercular agents. 17 Furthermore, a series of N 1 -acetamide uracils, analogues to the compounds obtained in this study, exhibited immunosuppressant antigen conjugates. 18, 19 The introduction of a trifluoromethyl group into bioactive molecules often increases their therapeutic efficiency due to an increase in lipophilicity. 20, 21 Thus, pyrimidines bearing a trifluoromethyl group have demonstrated a variety of activities such as herbicidal, [22] [23] [24] [25] [26] [27] insecticidal, 28, 29 acaricidal, 30 fungicidal, 30 antitumoral, 31 and antiviral, 32 just to mention a few. Trichloromethyl substituted heterocycles have been the subject of fewer studies. However, recent investigations have shown that, in some cases, trichloromethyl-containing heterocycles are more active than the corresponding trifluoromethyl-substituted analogues. For example, NTPDase inhibitory effects in synaptosomes from rat cerebral cortex, 33 antinociceptive effects in mice, 34 and hypothermic and antipyretic effects 35 have been reported.
As part of our ongoing program to develop new methods and molecular scaffolds that aggregate both novelty and potential for biological activity, this study aims to perform N 1 -alkylation of 4-trichloromethylpyrimidin-2(1H)-ones and two other related dihydropyrimidin-2(1H)-ones with selected alkylating agents. In a previous study, it was found that 1-(5,5,5-trichloro-2-methoxy-4-oxopent-2-en-1-yl)-4-trichloromethyl-pyrimidin-2(1H)-one (7) exhibited a potent cyclin-dependent kinase inhibition. 36 However, the low solubility of this compound made further studies difficult. Thus, as an extension of that study 37 we now synthesize a series of derivatives of compound 7 in order to generate new compounds with increased solubility and potential for biological activity.
Results and Discussion
This study was carried out in three parts: in the first, we examined the N-alkylation reaction of 4-trichloromethylpyrimidin-2(1H)-one (1) 22 with the alkylating agents 2-4 ( Fig. 1) .
Using the reaction conditions reported in Figure 1 , pyrimidinone 1 reacted with all three alkylating agents furnishing the respective N 1 -alkylated products 5, 6, and 7 in 60, 95, and 60% yields, respectively. In fact, compound 7 had already been obtained in a previous work. 37 Curiously, using the same conditions, pyrimidines 1 failed to react with 5-bromo-1,1,1-trifluoro-4-methoxypent-3-en-2-one (a trifluoromethylated analogue of enone 4).
In the second part of this study, we examined the N-alkylation reaction of some dihydro-derivatives of 4-trichloromethylpyrimidin-2(1H)-one (1) according to Figure 2 . The dihydropyrimidinone 8 was obtained from the reaction of pyrimidinone 1 by refluxing the latter in methanol for six hours. 39 The N-alkylation reaction of dihydropyrimidinone 8 with all three alkylating agents selected for this study failed to give the expected products. Actually, compound 8 was not stable and during the alkylation reaction it was converted back to its precursor 1 and yielding the same products reported in Figure 1 . Dihydropyrimidinone 9 was obtained in 91% yield from the bromination of dihydropyrimidinone 8 with bromine in methanol under reflux for 16 hours. The bromine at the 5-position stabilized the dihydropyrimidine, probably by steric effects. 40 Thus compound 9 reacted with alkylating agents 2 and 3 to give the N 1 -alkylated products 10 and 11, respectively, both in 60% yield. However, compound 9 failed to react with the brominated enone 4. Pyrimidine 9 was submitted to alkylation because it exhibited significant inhibition of ATP and ADP hydrolysis in synaptosomes from rat cerebral cortex. Table 1 reports the optimized reaction conditions and yields for the synthesis of compounds 5-7, 10 and 11. For the compounds that were not formed, the conditions included reaction times and an alternate base, sodium hydride.
In the third part of this study, we examined the reaction of 7 with a series of primary amines. Compound 7 exhibited potent cyclin-dependent kinase inhibition, in preliminary assays, however, the very low solubility of 7 made further studies difficult. Reactions of compound 7 with secondary amines were carried out furnishing a series of 1-(2-alkylamine-5,5,5-trichloro-4-oxopent-2-en-1-yl)-4-trichloromethylpyrimidinones in good yields 21 In the same study, the reaction of compound 7 with primary amines rendered a complex mixture of products. In this report, a modified procedure using a large excess (5-10 times) of the primary amines in acetonitrile was carried out and an unexpected result was found. Instead of the Michael addition of the amines followed by the elimination of the alkoxy group, as is usually observed for parent enones, [41] [42] [43] [44] [45] [46] [47] [48] [49] the substitution of the CCl 3 group by the primary amines also occurred simultane- Figure 3 . So far, no evidence of such a double-substitution has been observed for trichloro-or trifluoromethylated enones. Compounds 12a-g were isolated by filtration and the solids were washed with acetonitrile (10 mL) and twice with dichloromethane (10 mL) to remove the excess of amines. The solid products 12a-g showed high purity after drying in a desiccator. Compounds were analyzed by 1 H and 13 C NMR and purity was confirmed by HPLC, elemental analysis or HRMS. Representative compounds were also analyzed by 2D-NMR COSY and HMQC experiments. (ii) Table 2 shows the optimized reaction conditions and yields for the synthesis of compounds 12a-g.
The retention time of compounds 12b-g was determined by liquid chromatography (HPLC) as described in the experimental part. All products were eluted on a C-18 column with a methanol-water gradient of 40 to 100% of methanol for 10 minutes and kept at 100% of methanol for 5 minutes. Products 12b-g eluted with retention times of 8.17, 11.43, 10.81, 3.08, 4.37, and 12.44, respectively, while compound 12a did not elute under this condition. One can observe that the hydroxyl-alkyl derivatives 12e and 12f are the most soluble products and can also be considered nucleoside analogues.
Conclusion
In conclusion, we have shown that 4-trichloromethylpyrimidin-1H-2-one (1) reacted positively with all three alkylating agent used in this work. The 4-methoxy-4-trichloromethyl-3,4-dihydropyrimidin-2(1H)-one (8) failed to furnish alkylated products, however, bromination at the 5-position of compound 8 resulted in a more stable compound (9) that was accessible to alkylation with 2-chloroacetamide and diethyl 2-bromomalonate, but failed to react with enone 4. In addition, compound 7 underwent an unexpected double addition substitution of the methoxy and the CCl 3 groups by reaction with primary amines, furnishing a series of new enamides 12a-g, in moderate yields.
experimental
Unless otherwise indicated, all commercial reagents and solvents were obtained from commercial suppliers and used without further purification. Thin layer chromatography (TLC) was performed using Silica Gel plates GF 254 , 0.25 mm thickness. For visualization, TLC plates were either placed under ultraviolet light, or stained with iodine vapor. All melting points were determined on a Reichert Thermovar apparatus and are uncorrected. The CHN microanalyses were performed on a PerkinElmer 2400 elemental analyzer from the Department of Chemistry at the Universidade de São Paulo (USP), São Paulo, SP, Brazil. High resolution mass spectra were recorded on ESI-mode. 1 H and 13 C NMR were recorded on a Bruker DPX 400 spectrometer ( 1 H at 400.13 MHz and 13 C at 100.62 MHz) in DMSO-d 6 or CDCl 3 , using TMS as the internal reference. HPLC spectra were recorded on a HP 1100 chromatograph equipped with UV/Vis DAD, reverse phase C-18 column (100 mm × 2.1 mm, 5 µm). Compounds were eluted in a methanol-water gradient (1 mL/min.) from 40% to 100% of methanol for 10 min. and kept at 100% of methanol for 5 min. Typical procedure for the synthesis of compound 5-7, 10, and 11
To a mixture of pyrimidinones 1, 8, and 9 (2.0 mmol) and potassium carbonate (0.27 g, 2.0 mmol) in acetone (see Table 1 ), was added the alkylating agents (2.0 mmol). Mixtures were stirred at room temperature or under reflux (see Table 1 ) and followed by TLC until the reaction was completed (16-24 h). The solvent was removed on a rotary evaporator, and water (50 mL) was then added before extracting with ethyl acetate (3 × 20 mL). The combined organic layers were dried with anhydrous MgSO 4 and concentrated to give the pure products.
2-[2-Oxo-4(trichloromethyl)pyrimidin-1(2H)-yl]acetamide (5)
Yield 
5-Bromo-4-trichloromethyl-4-methoxy-3,4-dihydropyrimidin-2(1H)-one (9)
To a solution of pyrimidine 8 (0.245 g, 1.0 mmol) in methanol (10 mL), bromine (0.28 g 1.7 mmol) was added and the mixture was refluxed for 16 hours. The reaction mixture was concentrated and product 9 precipitated, isolated by filtration and recrystallized from methanol to give compound 9 in 91% yield; mp 198-200 °C.
¹H Typical procedure for the synthesis of compounds 12a-g To a mixture of 7 (0.86 g, 2 mmol) and acetonitrile was added an excess of primary amines (10-20 mmol). The mixture was stirred at room temperature and followed by TLC until the reaction was completed (see Table 2 ). The resulting mixture was filtered, washed with acetonitrile (1 × 10 mL) and dichloromethane (2 × 10 mL) and dried in a desiccator under vacuum. Products 12a-g were obtained in high purity from this procedure.
N-Methyl-3(methylamino)-4-[2-oxo-(trichloromethyl)-pyrimidin-1(2H)-yl]-but-2-enamide (12a)
Yield: 50%; light yellow solid comprised by E-and Z-isomers; mp 263-267 °C.
¹H 
